Risk stratification of adolescents for the screening of non‐alcoholic fatty liver disease

Non‐alcoholic fatty liver conditions in adolescence are associated with premature mortality in adulthood. Effective screening could impact the population burden of this disease.

[1]  A. Geerts,et al.  Intensive lifestyle management improves steatosis and fibrosis in pediatric non-alcoholic fatty liver disease. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  R. Lubetzky,et al.  Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD - an interventional pilot study , 2021, BMC Pediatrics.

[3]  J. Ludvigsson,et al.  Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. , 2021, Journal of hepatology.

[4]  G. Abrams,et al.  Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018 , 2021, Clinical pediatrics.

[5]  R. Passman,et al.  Cardiovascular Risk Factors in Young Adolescents: Results from the National Health and Nutrition Examination Survey 1988–2016 , 2021, Southern medical journal.

[6]  J. Stoker,et al.  Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity , 2020, European Radiology.

[7]  G. Perseghin,et al.  Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the National Health and Nutrition Examination Survey 2017-2018. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  L. Mohadjer,et al.  National Health and Nutrition Examination Survey, 2015-2018: Sample Design and Estimation Procedures. , 2020, Vital and health statistics. Series 2, Data evaluation and methods research.

[9]  Hyun Joo Shin,et al.  Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard , 2019, BMC Pediatrics.

[10]  Rohit Loomba,et al.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. , 2019, Gastroenterology.

[11]  B. Neuschwander‐Tetri,et al.  Vibration‐Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  Xuchen Zhang,et al.  Non-alcoholic fatty liver disease: An expanded review , 2017, World journal of hepatology.

[13]  D. Larizza,et al.  Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter , 2017, BMC Gastroenterology.

[14]  S. Daniels,et al.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) , 2017, Journal of pediatric gastroenterology and nutrition.

[15]  Jiayi Hou,et al.  Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. , 2016, JAMA pediatrics.

[16]  M. Jonas,et al.  Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. , 2016, The Journal of pediatrics.

[17]  C. Sirlin,et al.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease , 2015, Hepatology.

[18]  Zhen Wang,et al.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  C. Boesch,et al.  Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys , 2012, Diabetes.

[20]  C. Ogden,et al.  Anthropometric reference data for children and adults: United States, 2007-2010. , 2012, Vital and health statistics. Series 11, Data from the National Health Survey.

[21]  Katherine M Flegal,et al.  Changes in terminology for childhood overweight and obesity. , 2010, National health statistics reports.

[22]  F. Marra,et al.  Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis , 2008, Hepatology.

[23]  Peter Bennett,et al.  The metabolic syndrome in children and adolescents – an IDF consensus report , 2007, Pediatric diabetes.

[24]  A. Andriulli,et al.  Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. , 2006, World journal of gastroenterology.

[25]  M. Manco,et al.  Effect of vitamin E on aminotransferase levels and insulin resistance in children with non‐alcoholic fatty liver disease , 2006, Alimentary pharmacology & therapeutics.

[26]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[27]  S. Daniels,et al.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children. , 2016, Journal of pediatric gastroenterology and nutrition.

[28]  Kelly Dedel,et al.  Underage drinking. , 1993, JAMA.